Strata Critical Medical Inc (SRTA) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Strata Critical Medical Inc   (NASDAQ: SRTA)


Strata Critical Medical Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Strata Critical Medical Inc's ROI in the third quarter of 2026?
Strata Critical Medical Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -8.39%.

Within the Healthcare sector 130 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 438, from total ROI ranking in the second quarter of 2026 at 533.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 14.88 % 23.31 % 18.25 % 9.31 % 0.49 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 284 287 307 306 307
Return On Investment (TTM) -8.39 % 13.34 % 16.15 % 15.07 % 15.69 %
SRTA's Overall Ranking # 438 # 533 # 445 # 3094 # 3229
Seq. Investment Change TTM -1.94 % 3.67 % 6.07 % 6.54 % 5.26 %
Seq. Net Income Change TTM - -14.41 % 13.66 % 2.38 % -
Net Income (TTM) in Millions -25 40 47 41 40




Return On Investment SRTA's Ranking
Within: No.
Industry # 43
Sector # 131
Overall # 438

Return On Investment Statistics
High Average Low
16.15 %
-6.91 %
-20.08 %
(Mar 31 2026)   (Sep 30 2024)







Financial Statements
Strata Critical Medical Inc's III. Quarter Investments $ 284 Millions SRTA's Balance sheet
Strata Critical Medical Inc's III. Quarter Income $ -8 Millions Quarterly SRTA's Income Statement
SRTA's Income by Division See SRTA's Income by Division


SRTA Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Sep 30 2021)
2021
Total Investments in Millions 306 234 259 298 334
Y / Y Investment Growth 30.66 % -9.83 % -13.06 % -10.62 % 20.33 %
Net Income in Millions 41 -27 -56 -27 -40
Y / Y Net Income Growth - - - - -
Annual Return On Investment 13.53 % -11.67 % -21.61 % -9.13 % -12 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 13.53 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SRTA's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SRTA's Competitors
Subscribers only: Roi for Strata Critical Medical Inc's Suppliers
Subscribers only: Return On Investment for SRTA's Customers

Other Ratios
SRTA's Roa SRTA's Inventory Turnover Ratio SRTA's Growth Rates SRTA's Dividend Statistics
SRTA's Profitability Ratios SRTA's Asset Turnover Ratio SRTA's Dividend Growth
SRTA's Roe SRTA's Valuation Ratios SRTA's Financial Strength Ratios SRTA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI


Date modified: 2026-11-04T15:26:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.